The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
of the student body are Arab Israeli
students
countries
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSAs Seen in Times of Israel
The oldest and leading Arab-owned med-tech company in Israel started in a city in the Israeli periphery known more as Jesus’s hometown than a high-tech hub. But for Reem Younis, 59, who grew up in a working-class Christian family in Nazareth, there was no better location to found what has become a giant in Israel’s med-tech industry.
In 1993, alongside her husband, Imad, she established Alpha Omega, one of the world’s top manufacturers of electrodes and other medical devices that record the activity of neurons from within the brain.
Today, researchers and neurosurgeons worldwide use Alpha Omega equipment to guide them, much like the Israeli navigational system Waze, toward the best place to implant deep brain stimulation (DBS) electrodes inside the brain. These electrodes are used to treat disorders associated with neurological conditions such as epilepsy and Parkinson’s disease.
Reem and Imad Younis are both Technion alumni.
by
www.timesofisrael.com (opens in a new tab)
on
August 19, 2024
Explore how Nazareth became a hub for medical technology with Alpha Omega, founded by Reem and Imad Younis in 1993.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Biotech / Alumni / Engineering / Neurological Diseases / Startups / Women /
Why do so many life-saving technologies never make it out of the lab? Prof. Marcelle Machluf demonstrates how combining scientific rigor with business vision is the only way to bring practical solutions to the patients who need them most. As a case in point, she shares her personal transformation from researcher to entrepreneur. This talk […]
Can the future of nutrition be more personalized, even down to our biology? A new study from the Technion suggests it can. Researchers in the Faculty of Biotechnology and Food Engineering recently discovered that men and women digest milk and plant-based milk alternatives differently — a breakthrough that could have far-reaching implications for nutrition science, […]
This op-ed is authored by Jenny Goldstein, chief development officer of the American Technion Society. For anyone who has faced a cancer diagnosis, or watched someone they love go through one, there is a particular anguish that comes with uncertainty. For me, that feeling is deeply personal. My father, an engineer whose love of science […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.